Venetoclax (Venclexta)
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Venetoclax (Venclexta), covering 2024-12-10 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory [Phase 1]